Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.650
+0.050 (1.92%)
Apr 30, 2024, 3:36 PM EDT - Market open

Armata Pharmaceuticals Revenue

In the year 2023, Armata Pharmaceuticals had annual revenue of $4.53M, a decrease of -17.77%. Revenue in the quarter ending December 31, 2023 was $1.53M with 45.39% year-over-year growth.

Revenue (ttm)
$4.53M
Revenue Growth
-17.77%
P/S Ratio
20.03
Revenue / Employee
$68,621
Employees
66
Market Cap
96.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.53M-979.00K-17.77%
Dec 31, 20225.51M1.03M23.11%
Dec 31, 20214.47M3.65M443.62%
Dec 31, 2020823.00K--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 2017115.00K-145.00K-55.77%
Dec 31, 2016260.00K-215.00K-45.26%
Dec 31, 2015475.00K66.00K16.14%
Dec 31, 2014409.00K328.00K404.94%
Dec 31, 201381.00K-583.00K-87.80%
Dec 31, 2012664.00K544.00K453.33%
Dec 31, 2011120.00K-8.60M-98.62%
Dec 31, 20088.72M-1.61M-15.62%
Dec 31, 200710.33M468.00K4.74%
Dec 31, 20069.86M2.99M43.50%
Dec 31, 20056.87M-2.78M-28.78%
Dec 31, 20049.65M-4.42M-31.41%
Dec 31, 200314.07M-5.26M-27.21%
Dec 31, 200219.33M453.00K2.40%
Dec 31, 200118.88M7.48M65.57%
Dec 31, 200011.40M4.56M66.52%
Dec 31, 19996.85M-662.25K-8.82%
Dec 31, 19987.51M6.18M465.71%
Dec 31, 19971.33M-926.59K-41.11%
Dec 31, 19962.25M1.41M167.57%
Dec 31, 1995842.46K--
Dec 31, 1994---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SHL Telemedicine 57.08M
Allurion Technologies 53.47M
Elutia 24.75M
Myomo 19.24M
Abeona Therapeutics 3.50M
BioXcel Therapeutics 1.38M
Revenue Rankings